Ledger.Open graph →
SEC Form D · filed December 19, 2024

Senti Biosciences, Inc

Offering
$120.6M
Sold
$37.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Michael A. Shah · South San Francisco, CAExec · DirectorBrenda Cooperstone · SOUTH SAN FRANCISCO, CADirectorKanya Rajangam · SOUTH SAN FRANCISCO, CAExecJames Collins · SOUTH SAN FRANCISCO, CADirectorYvonne Li · SOUTH SAN FRANCISCO, CAExecDonald Tang · SOUTH SAN FRANCISCO, CADirectorTimothy Lu · SOUTH SAN FRANCISCO, CAExec · DirectorEdward Mathers · SOUTH SAN FRANCISCO, CADirectorFran Schulz · SOUTH SAN FRANCISCO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗